LIFE12 ENV/ES/ DELIVERABLE D.B.2.2: REPORT: PROTOTYPE IN A REAL INSTALLATION URBAN WATER FACILITIES.

Transcripción

1 LIFE Project Number LIFE12 ENV/ES/ DELIVERABLE D.B.2.2: REPORT: PROTOTYPE IN A REAL INSTALLATION URBAN WATER FACILITIES. ADNATUR: Demonstration of natural coagulant use advantages in physical & chemical treatments in industry and urban waste water. Page 1

2 CONTENTS 1. INTRODUCTION ADEQUACY OF THE FACILITIES IN URBAN WWTP IN ONTINYENT START UP, FINE-TUNING AND OPTIMIZATION OF THE PROTOTYPE IN URBAN WWTP IN ONTINYENT Transport of the prototype from SERVYECO to Urban WWTP in Ontinyent Installation of the prototype in urban WWTP and adjustment of all the operation parameters Optimization of the prototype in Urban Wastewater Treatments Main conclusions during demonstration phase in Urban WWTP in Ontinyent ANNEX Analysis File Urban WWTP in Ontinyent Microorganisms Control Page 2

3 1. INTRODUCTION This report collects all developed activities in urban WWTP in Ontinyent, during the industrial scale demonstration phase of the project. It comprises all the actions related to: The preparation of the facilities in WWTP in Ontinyent Transport of the prototype from SERVYECO to WWTP in Ontinyent Installation of the prototypes in WWTP in Ontinyent and adjustment of all the operation parameters. Optimization of the prototypes in WWTP in Ontinyent, studying the most important parameters as Chemist Oxygen demand (COD), Total suspended solid (TSS), Total phosphorus (TP), N-NH4 and Conductivity. Finally, it was evaluated the efficiency of the proposed eco-innovative technology, always in comparison with the current treatment of the wastewaters in Urban WWTP. Establishment of the conclusions studying all the obtained results Page 3

4 2. ADEQUACY OF THE FACILITIES IN URBAN WWTP IN ONTINYENT EGEVASA choose the urban WWTP located in Ontinyent to perform the demonstration with second prototype, because they have very completed facilities to treat wastewaters and they consume high quantities of ferric chloride, in order to remove the total phosphorus. People from EGEVASA, responsible of WWTP in Ontinyent, choose the adequate place, prepare the installations where located the prototype and all the required connections (water supply, power, compressed air ). a) b) Figure 1: Pictures of potential places to locate the prototype: a) Close to the tertiary treatment, which nowadays is empty. b) Close to the biological reactors and decantation units. On the other hand, people from SEVYECO and AITEX performed some visits in order to know the current operation mode of WWTP in Ontinyent, being that the treatment procedures were more complicated than industrial ones. The prototype should reproduce part of the real treatment in plant, to obtain good results with the demonstration, using ADNATUR coagulant. In real plant, the biological depuration was done in two phases; Phase A, where the major quantity of organic pollution was degraded and Phase B, where the nutrients nitrogen and phosphorus were removed. The prototype should receive the wastewater coming from decantation unit in Phase A, it should reproduce biological degradation of nitrogen in Phase B and eliminate the total phosphorous with the physic-chemical treatment, (see figure 2). a) Figure 2: Pictures of real installation in WWTP in Ontinyent a) Decantation unit of Phase A b) Biological reactor of phase B with nitrification and denitrification processes. Page 4

5 The most important requirements to install the prototype were: - Size of the prototype: 7 m long X 2 m wide. - Electrical connection: three phase connection, neutral line for power of 4 kw. - Water supply diameter of pipes: 24,4 mm. - The outlet is ready for download by gravity. 7m 2m Figure 3: Picture of second prototype in SERVYECO facilities. As it said, the prototype should be feed directly with the wastewater coming from current facilities; the canalizations can be seen in figure 4-a, which were connected to the prototype inlet in figure 4-b. Compressed air connections were needed too, and a pipe to supply clean water to prepare the chemical solutions with natural coagulant. Electrical connections were done too with the distribution panel and compressor, (see figure 4). a) a) a) Figure 4: Pictures of a) Wastewater connections with the prototype b) Inlet to the prototype and electrical panel distribution c) Compressor to aerate the prototype biological reactor. Page 5

6 3. START UP, FINE-TUNING AND OPTIMIZATION OF THE PROTOTYPE IN URBAN WWTP IN ONTINYENT 3.1 Transport of the prototype from SERVYECO to Urban WWTP in Ontinyent The pilot plant was moved from SERVYECO facilities to WWTP in Ontinyent during April It was necessary to subcontract a lorry with crane services to move and discharge the pilot plant. Figure 5 Pictures show both sides of the prototype in lorry crane in WWTP of Ontinyent. People from SERVYECO, EGEVASA and AITEX were attending the discharging works of the prototype in WWTP of Ontinyent. a) b) c) Figure 6. Pictures show both parts of pilot plant locate in definite emplacement. a) Biological reactor and Physic-chemical treatment b) Decantation unit c) Complete prototype. Page 6

7 3.2. Installation of the prototype in urban WWTP and adjustment of all the operation parameters. The urban WWTP facilities is constituted by a pretreatment with a scabble unit, which remove the largest objects that have been trapped by the wastewaters, and degreaser. Then the wastewaters are treated in secondary treatment with two biological reactors; Phase A, removes the organic pollution and Phase B, removes the nutrients with nitrification and denitrification processes. The plant has too a tertiary treatment with coagulation and flocculation processes but nowadays is empty because the quality of water accomplish the poured law without this treatment. Finally, the treated wastewaters are disinfected with ultraviolet lamps. Although initially it was going to work in the prototype with wastewaters coming from the tertiary, finally, the pilot plant was fed with the wastewater, coming from decantation unit of Phase A, where the organic contamination was eliminated, in order to eliminate the nitrogen and phosphorous, (see Figure 7). Figure 7: Treatment flow in urban WWTP in Ontinyent. Pilot plant has been fed with wastewater coming from decantation of Phase A, in order to reproduce the Phase B in pilot plant. Phase B eliminates nitrogen and phosphorous During demonstration phase in pilot plant, ferric chloride has been substituted by ADNATUR coagulant, in order to remove the phosphorus and improved the sludge quality to obtain biogas. Figure 8 shows some photographs of different parts of prototype, which was empty, before filling it of wastewater coming from decantation unit of Phase A. Page 7

8 a) b) Figure 8. Pictures show the interior of two parts of pilot plant. a) Biological reactor, with the aeration system b) Dosage tank and mixture of physic-chemical treatment. The connections were performed in prototype, some of them can see in figures 9 and 10: - Inlet wastewater, coming from decantation unit of Phase A - Recirculation of sludges in biological reactor - Chemical dosages - Tube connection between physic-chemical mixture tank and decantation unit - Outlet treated wastewater in prototype. - Outlet separated sludges in decantation unit a) b) c) Figure 9. Pictures show the connections of pilot plant. a) Inlet wastewater, coming from decantation unit of Phase A b) Recirculation of sludges in biological reactor. c) Chemical dosages Page 8

9 a) b) Figure 10. Pictures show the connections of pilot plant. a) Tube connection between physicchemical mixture tank and decantation unit b) Outlet treated wastewater in prototype and outlet separated sludges in decantation unit. Page 9

10 3.3. Optimization of the prototype in Urban Wastewater Treatments Prototype operation activities in urban WWTP in Ontinyent. Operation and optimizing actions were developed from May 2015, to July These actions were done through the analysis of treated wastewaters, studying the most important parameters as chemist oxygen demand (COD), total suspended solid (TSS),, conductivity, total phosphorous (TP) and ammoniac nitrogen (N-NH4). Two samples were collected, four or five times a week: - One sample from Decantation PHASE A (Inlet to pilot reactor) - One sample from pilot, outlet The evolution of obtained results are presented in figures from 11 to 32: Figure 11. COD, TSS and CONDUCTIVITY results from the prototype during May Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour Public Hydraulic Domain, according to wastewater Spanish law. Page 10

11 Figure 12. N-NH4 and TP results from the prototype during May Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour public hydraulic domain, according to wastewater Spanish law. During first month of functioning, it was necessary to adjust some variables and parameters in pilot plant as aeration, sludge recirculation, dosage of chemicals, quantity, concentration and viscosity of the chemicals in preparation procedures, residence time of wastewaters, wastewater flow and flow of sludge discharge. The efficiencies in COD and TSS eliminations were so good, close to 90% even though the elimination of nutrients were so good because most of them are in the discharge limit (see figures 11 and 12). Figure 13. COD, TSS and CONDUCTIVITY results from the prototype during June Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour Public Hydraulic Domain, according to wastewater Spanish law. It can be seen in figure 13 in spite of the low values of discharge limit to the Public Hydraulic Domain, the treated wastewater from prototype values were just in the discharge limits. Page 11

12 Figure 14. N-NH4 and TP results from the prototype during June Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour public hydraulic domain, according to wastewater Spanish law. After two months of functioning it can been said that the prototype works so good, in spite of the difficulty of reproducing the biological reactor functions; nitrification and denitrification. (See figure 16). Regarding conductivity, it can been seen in some charts that decrease lightly, because of this coagulant do not need any chemical to adjust the. Figure 15. COD, TSS and CONDUCTIVITY results from the prototype during July Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour Public Hydraulic Domain, according to wastewater Spanish law. Page 12

13 Figure 16. N-NH4 and TP results from the prototype during July Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour public hydraulic domain, according to wastewater Spanish law. Figure 17. COD, TSS and CONDUCTIVITY results from the prototype during August Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour Public Hydraulic Domain, according to wastewater Spanish law. Page 13

14 Figure 18. N-NH4 and TP results from the prototype during August Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour public hydraulic domain, according to wastewater Spanish law. Figure 19. COD, TSS and CONDUCTIVITY results from the prototype during September Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour Public Hydraulic Domain, according to wastewater Spanish law. Page 14

15 Figure 20. N-NH4 and TP results from the prototype during September Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour public hydraulic domain, according to wastewater Spanish law. Figures 15 to 20 show the obtained results in prototype during summer months, when the temperatures are son high and the microorganism decrease their activity and consequently the depuration efficiency, however the results of COD, TSS and Nutrients are very good. The benefits of organic coagulant it is seen reflected in the state and activity of the microorganism. Figure 21. COD, TSS and CONDUCTIVITY results from the prototype during October Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour Public Hydraulic Domain, according to wastewater Spanish law. Page 15

16 Figure 22. N-NH4 and TP results from the prototype during October Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour public hydraulic domain, according to wastewater Spanish law. Figure 23. COD, TSS and CONDUCTIVITY results from the prototype during November Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour Public Hydraulic Domain, according to wastewater Spanish law. On the contrary, the low temperatures affect the nitrification and denitrification processes, so it can be seen some punctual results in the elimination of nutrients worst during this months of autumn and winter. (See figures 24 to 32). Page 16

17 Figure 24. N-NH4 and TP results from the prototype during November Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour public hydraulic domain, according to wastewater Spanish law. Figure 25. COD, TSS and CONDUCTIVITY results from the prototype during December Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour Public Hydraulic Domain, according to wastewater Spanish law. Page 17

18 Figure 26. N-NH4 and TP results from the prototype during December Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour public hydraulic domain, according to wastewater Spanish law. Figure 27. COD, TSS and CONDUCTIVITY results from the prototype during January Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour Public Hydraulic Domain, according to wastewater Spanish law. Page 18

19 Figure 28. N-NH4 and TP results from the prototype during January Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour public hydraulic domain, according to wastewater Spanish law. Figure 29. COD, TSS and CONDUCTIVITY results from the prototype during February Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour Public Hydraulic Domain, according to wastewater Spanish law. Page 19

20 Figure 30. N-NH4 and TP results from the prototype during February Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour public hydraulic domain, according to wastewater Spanish law. Figure 31. COD, TSS and CONDUCTIVITY results from the prototype during March Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour Public Hydraulic Domain, according to wastewater Spanish law. Page 20

21 Figure 32. N-NH4 and TP results from the prototype during March Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour public hydraulic domain, according to wastewater Spanish law. Prototype optimization activities in Urban WWTP in Ontinyent. After nearly one year working with the prototype with the same ADNATUR dosage than Ferric chloride in real installations, it was decided to begin with the optimizing actions decreasing the coagulant dosage. As it can see in table 1, the dosage pumps are programed to dosage the same quantity than in real installation; however, there were some little positive and negative deviations: Table 1 collects coagulant dosage during the year: MONTH DOSAGE of Ferric DOSAGE of ADNATUR REDUCTION of coagulant Clhoride (ppm) coagulant (ppm) consumption (%) May ,00 118,00-28,2 June ,00 104,40-15,5 July ,01 102,20-2,2 August ,00 107,64 8,8 September ,00 118,00-8,2 October ,01 117,13 0,0 November ,00 114,70 4,4 December ,99 117,59 3,6 January ,00 112,50 4,7 February ,00 118,00-16,8 March ,01 109,95-5,7 Average 108,64 112,74-3,7 Table 1. Coagulant dosages during four first months. The elimination of phosphorous depends the physic-chemical treatment. After revising all the obtained results, it can be concluded that the coagulant is working good but the cost is too high so after some jar test trials it was decided to reduce the dosage by half. Page 21

22 Figure 33. Pictures of Jar Test trials to optimize in lab the ADNATUR coagulant, in order to reduce the cost of the treatment. Figure 34. Pictures of results of Jar Test; after reducing the dosage of ADNATUR coagulant by half the sedimentation volume of the sludges is better using ADNATUR coagulant than Ferric chloride. As of April 2016 the prototype in urban WWTP in Ontinyent were dosaged with nearly 50 ppm of ADANATUR coagulant. The results of this month can be seen in following charts, (figures 35 and 36), they were not so good, the efficiency of COD and TSS decreased and even though there were some results above discharge limits. Regarding nutrients elimination, the results can be improved because there were some of them above discharge limit too. In spite of that, it was decided going on with this dosage during the next month of May. Page 22

23 Figure 35. COD, TSS and CONDUCTIVITY results from the prototype during April Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour Public Hydraulic Domain, according to wastewater Spanish law. Figure 36. N-NH4 and TP results from the prototype during April Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour public hydraulic domain, according to wastewater Spanish law. Page 23

24 Figure 37. COD, TSS and CONDUCTIVITY results from the prototype during May Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour Public Hydraulic Domain, according to wastewater Spanish law. The outlet values of COD and TSS of the prototype during May were better than in April so during June the dosage is maintained in half. It can see in figure 37, the first values in the month were worst but from 12 of May they were improving and most of them are below discharge limit. Regarding nutrients elimination it is necessary to notice that the nitrification and denitrification processes were not functioning good but the phosphorous elimination is so good again. Figure 38. N-NH4 and TP results from the prototype during May Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour public hydraulic domain, according to wastewater Spanish law. Page 24

25 The problematic related with nitrification and denitrification process were associated to the functioning of the compressor that gave some problems at the end of the demonstration related with the maintenance of it. Figure 39. COD, TSS and CONDUCTIVITY results from the prototype during June Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour Public Hydraulic Domain, according to wastewater Spanish law. The outlet values of COD and TSS of the prototype during June were good and the elimination of phosphorous too, there was one value above discharge limit but it was similar when the prototype worked with more ADNATUR coagulant. (See figures 39 and 40). Figure 40. N-NH4 and TP results from the prototype during June Inlet wastewater from decantation unit of Phase A and treated wastewater in prototype. Remark: discharge limits are the limits to pour public hydraulic domain, according to wastewater Spanish law. Page 25

26 Regarding coagulant dosages, it can be confirm the optimum dosage of ADNATUR coagulant in nearly 50 ppm. Table 2 collects the evolution of coagulant dosage during demonstration phase in urban WWTP in Ontinyent: MONTH DOSAGE of Ferric DOSAGE of ADNATUR REDUCTION of coagulant Clhoride (ppm) coagulant (ppm) consumption (%) May ,00 118,00-28,2 June ,00 104,40-15,5 July ,01 102,20-2,2 August ,00 107,64 8,8 September ,00 118,00-8,2 October ,01 117,13 0,0 November ,00 114,70 4,4 December ,99 117,59 3,6 January ,00 112,50 4,7 February ,00 118,00-16,8 March ,01 109,95-5,7 April ,00 53,36 46,64 May ,00 52,66 46,26 June ,00 52,78 46,14 Average 108,64 112,74 6 Table 2. Coagulant dosages during demonstration phase in urban WWTP in Ontinyent Main conclusions during demonstration phase in Urban WWTP in Ontinyent. Summarizing the obtained conclusions from the demonstration phase, could be said that the obtained results with ADNATUR coagulant in urban WWTP in Ontinyent facilities are also similar than nowadays coagulant (Ferric chloride), however the amount of ferric chloride is twice more than the amount needed with ADNATUR coagulant: Total Phosphorus reductions are between 50-80% obtaining values, which are almost always below the discharge limit, 1 mg/l, average annual value. N-NH4 reductions are between 70-90%, obtaining values which are almost always below discharge limit, 5,4 mg/l ADNATUR coagulant do not interfere in negative way the biological process, as show COD and TSS values. The benefits of organic coagulant it is seen reflected in the good state and activity of the microorganism. ADNATUR coagulant does not modify the CONDUCTIVITY because it does not need neutralizing agent that has been completely removed. Page 26

27 4. ANNEX 4.1. Analysis File Urban WWTP in Ontinyent Fecha del muestreo: Coagulante p.p.m. 94 p.p.m. 8, , SST 186 mg/l 15 mg/l DQO 426 mg O2/l 52 mg O2/l Pt 6,2 mg Pt/l 0,7 mg Pt/l N-NH4 36,7 mg N/l 10 mg N/l Page 27

28 Fecha del muestreo: Coagulante p.p.m. 94 p.p.m. 7, , SST 148 mg/l 54 mg/l DQO 411 mg O2/l 96 mg O2/l Pt 6,7 mg Pt/l 3,2 mg Pt/l N-NH4 31,9 mg N/l 11,3 mg N/l Page 28

29 Fecha del muestreo: Coagulante 118 p.p.m. 92 p.p.m. 8 7, SST 157 mg/l 16 mg/l DQO 389 mg O2/l 59 mg O2/l Pt 5,9 mg Pt/l 1,2 mg Pt/l N-NH4 36,9 mg N/l 13,8 mg N/l Page 29

30 Fecha del muestreo: Coagulante 118 p.p.m. 92 p.p.m. 7,7 7, SST 135 mg/l 39 mg/l DQO 441 mg O2/l 111 mg O2/l Pt 5,7 mg Pt/l 1,5 mg Pt/l N-NH4 28,8 mg N/l 15 mg N/l Page 30

31 Fecha del muestreo: Coagulante 118 p.p.m. 92 p.p.m. 8,2 7, SST 101 mg/l 18 mg/l DQO 304 mg O2/l 58,4 mg O2/l Pt 4,7 mg Pt/l 1,8 mg Pt/l N-NH4 33,1 mg N/l 5,5 mg N/l Page 31

32 Fecha del muestreo: Coagulante 118 p.p.m. 92 p.p.m. 7,7 7, SST 92 mg/l 17 mg/l DQO 300 mg O2/l 71,8 mg O2/l Pt 4,8 mg Pt/l 2,2 mg Pt/l N-NH4 26 mg N/l 7 mg N/l Page 32

33 Fecha del muestreo: Coagulante 118 p.p.m. 92 p.p.m. 7,7 7, SST 741 mg/l 26 mg/l DQO 270 mg O2/l 75,4 mg O2/l Pt 16 mg Pt/l 2,56 mg Pt/l N-NH4 27,2 mg N/l 5,71 mg N/l Page 33

34 Fecha del muestreo: Coagulante 118 p.p.m. 92 p.p.m. 7,8 7, SST 129 mg/l 36 mg/l DQO 353 mg O2/l 83,7 mg O2/l Pt 5,54 mg Pt/l 3,57 mg Pt/l N-NH4 26,3 mg N/l 5,57 mg N/l Page 34

35 Fecha del muestreo: Coagulante 104 p.p.m. 94 p.p.m. 7, , SST 1589 mg/l 21 mg/l DQO 2412 mg O2/l 73 mg O2/l Pt 23,4 mg Pt/l 2,2 mg Pt/l N-NH4 29,6 mg N/l 5,61 mg N/l Page 35

36 Fecha del muestreo: Coagulante 104 p.p.m. 94 p.p.m. 7,9 7, SST 1007 mg/l 84 mg/l DQO 1806 mg O2/l 126 mg O2/l Pt 17,6 mg Pt/l 2,56 mg Pt/l N-NH4 28,8 mg N/l 5,4 mg N/l Page 36

37 Fecha del muestreo: Coagulante 104 p.p.m. 94 p.p.m. 7, , SST 82 mg/l 15 mg/l DQO 290 mg O2/l 56,9 mg O2/l Pt 5,38 mg Pt/l 1,23 mg Pt/l N-NH4 18,8 mg N/l 4,98 mg N/l Page 37

38 Fecha del muestreo: Coagulante 104 p.p.m. 94 p.p.m. 7, , SST 44 mg/l 94 mg/l DQO 190 mg O2/l 124 mg O2/l Pt 4,18 mg Pt/l 2,58 mg Pt/l N-NH4 22,4 mg N/l 3,18 mg N/l Page 38

39 Fecha del muestreo: Coagulante 104 p.p.m. 94 p.p.m. 7, , SST 76 mg/l 12 mg/l DQO 291 mg O2/l 47,2 mg O2/l Pt 5,13 mg Pt/l 1,07 mg Pt/l N-NH4 26 mg N/l 3,8 mg N/l Page 39

40 Fecha del muestreo: Coagulante 104 p.p.m. 94 p.p.m. 7, , SST 1506 mg/l 87 mg/l DQO 1485 mg O2/l 267 mg O2/l Pt 32,4 mg Pt/l 4,07 mg Pt/l N-NH4 7,34 mg N/l 21,3 mg N/l Page 40

41 Fecha del muestreo: Coagulante 104 p.p.m. 94 p.p.m. 7, , SST 97 mg/l 164 mg/l DQO 236 mg O2/l 228 mg O2/l Pt 4,54 mg Pt/l 4,1 mg Pt/l N-NH4 22,9 mg N/l 2,44 mg N/l Toxicidad u. T < 2 u. T Escherichia coli 4, ufc/ml Page 41

42 Fecha del muestreo: Coagulante 102 p.p.m. 100 p.p.m. 7, , SST 76 mg/l 16 mg/l DQO 359 mg O2/l 144 mg O2/l Pt 4,6 mg Pt/l 1,58 mg Pt/l N-NH4 27 mg N/l 4,12 mg N/l Page 42

43 Fecha del muestreo: Coagulante 102 p.p.m. 100 p.p.m. 7, , SST 102 mg/l 376 mg/l DQO 261 mg O2/l 483 mg O2/l Pt 4,68 mg Pt/l 8,4 mg Pt/l N-NH4 24,6 mg N/l 3,33 mg N/l Page 43

44 Fecha del muestreo: Coagulante 102 p.p.m. 100 p.p.m. 7, , SST 130 mg/l 36 mg/l DQO 321 mg O2/l 74,2 mg O2/l Pt 5,26 mg Pt/l 2,34 mg Pt/l N-NH4 19,9 mg N/l 2,58 mg N/l Page 44

45 Fecha del muestreo: Coagulante 102 p.p.m. 100 p.p.m. 7, , SST 84 mg/l 9 mg/l DQO 235 mg O2/l 54,4 mg O2/l Pt 4,13 mg Pt/l 1,53 mg Pt/l N-NH4 31,8 mg N/l 6,92 mg N/l Page 45

46 Fecha del muestreo: Coagulante 102 p.p.m. 100 p.p.m. 7, , SST 123 mg/l 16 mg/l DQO 331 mg O2/l 54,6 mg O2/l Pt 5,25 mg Pt/l 1,18 mg Pt/l N-NH4 23,3 mg N/l 3,29 mg N/l Page 46

47 Fecha del muestreo: Coagulante 102 p.p.m. 100 p.p.m. 7, , SST 501 mg/l 14 mg/l DQO 770 mg O2/l 53,7 mg O2/l Pt 13,6 mg Pt/l 1,52 mg Pt/l N-NH4 24,6 mg N/l 2,94 mg N/l Toxicidad u. T < 2 u. T Escherichia coli 1, ufc/ml Page 47

48 Fecha del muestreo: Coagulante 102 p.p.m. 100 p.p.m. 7, , SST 107 mg/l 18 mg/l DQO 279 mg O2/l 63,2 mg O2/l Pt 5,07 mg Pt/l 1,02 mg Pt/l N-NH4 23,6 mg N/l 6,55 mg N/l Page 48

49 Fecha del muestreo: Coagulante 107 p.p.m. 118 p.p.m. 7,6 7, SST 48 mg/l 12 mg/l DQO 138 mg O2/l 47,7 mg O2/l Pt 4,22 mg Pt/l 1,28 mg Pt/l N-NH4 25 mg N/l 2,49 mg N/l Page 49

50 Fecha del muestreo: Coagulante 107 p.p.m. 118 p.p.m. 7,6 7, SST 52 mg/l 23 mg/l DQO 147 mg O2/l 59,2 mg O2/l Pt 3,14 mg Pt/l 1,32 mg Pt/l N-NH4 24 mg N/l 2,28 mg N/l Page 50

51 Fecha del muestreo: 11/08/2015 Coagulante 107 p.p.m. 118 p.p.m. 7, , SST 21 mg/l 13 mg/l DQO 69,8 mg O2/l 35,6 mg O2/l Pt 1,04 mg Pt/l 1,67 mg Pt/l N-NH4 24,1 mg N/l 5,63 mg N/l Page 51

52 Fecha del muestreo: Coagulante 107 p.p.m. 118 p.p.m. 7, ,5 966 SST 177 mg/l 9 mg/l DQO 292 mg O2/l 27,4 mg O2/l Pt 3,2 mg Pt/l 1,43 mg Pt/l N-NH4 17,2 mg N/l 4,84 mg N/l Page 52

53 Fecha del muestreo: Coagulante 118 p.p.m. 109 p.p.m. 7, , SST 102 mg/l 32 mg/l DQO 176 mg O2/l 82,1 mg O2/l Pt 5,4 mg Pt/l 1,58 mg Pt/l N-NH4 21,4 mg N/l 7,7 mg N/l Page 53

54 Fecha del muestreo: Coagulante 118 p.p.m. 109 p.p.m. 7, , SST 102 mg/l 32 mg/l DQO 176 mg O2/l 82,1 mg O2/l Pt 5,4 mg Pt/l 1,58 mg Pt/l N-NH4 21,4 mg N/l 7,7 mg N/l Page 54

55 Fecha del muestreo: Coagulante 118 p.p.m. 109 p.p.m. 7, , SST 81 mg/l 11 mg/l DQO 354 mg O2/l 53,3 mg O2/l Pt 6,26 mg Pt/l 1,35 mg Pt/l N-NH4 28,2 mg N/l 13,4 mg N/l Page 55

56 Fecha del muestreo: Coagulante 118 p.p.m. 109 p.p.m. 7,7 7, SST 98 mg/l 18 mg/l DQO 352 mg O2/l 58 mg O2/l Pt 6,65 mg Pt/l 2,18 mg Pt/l N-NH4 35,5 mg N/l 9,01 mg N/l Page 56

57 Fecha del muestreo: Coagulante 118 p.p.m. 109 p.p.m. 7,57 7, SST 101 mg/l 24 mg/l DQO 335 mg O2/l 63,8 mg O2/l Pt 7,57 mg Pt/l 1,73 mg Pt/l N-NH4 26,5 mg N/l 6,01 mg N/l Page 57

58 Fecha del muestreo: Coagulante 118 p.p.m. 109 p.p.m. 7, , SST 71 mg/l 71 mg/l DQO 412 mg O2/l 261 mg O2/l Pt 5,02 mg Pt/l 5,19 mg Pt/l N-NH4 22,4 mg N/l 32,1 mg N/l Toxicidad. u. T u. T debido a un vertido incontrolado durante el fin de semana la depuradora no esta funcionando Page 58

59 Fecha del muestreo: Coagulante 118 p.p.m. 109 p.p.m. 8, , SST 102 mg/l 93 mg/l DQO 374 mg O2/l 202 mg O2/l Pt 5,27 mg Pt/l 1,81 mg Pt/l N-NH4 31 mg N/l 19,8 mg N/l Toxicidad 13,8 u. T u. T Escherichia coli 6, ufc/ml Page 59

60 Fecha del muestreo: Coagulante 118 p.p.m. 109 p.p.m. 7,7 7, SST 73 mg/l 21 mg/l DQO 254 mg O2/l 71,3 mg O2/l Pt 2,52 mg Pt/l 0,718 mg Pt/l N-NH4 13,4 mg N/l 8,25 mg N/l Page 60

61 Fecha del muestreo: Coagulante 117 p.p.m. 117 p.p.m. 7,8 7, SST 75 mg/l 19 mg/l DQO 215 mg O2/l 73,9 mg O2/l Pt 3,63 mg Pt/l 1,12 mg Pt/l N-NH4 24,6 mg N/l 12,8 mg N/l Page 61

62 Fecha del muestreo: Coagulante 117 p.p.m. 117 p.p.m. 7,6 7, SST 87 mg/l 28 mg/l DQO 313 mg O2/l 103 mg O2/l Pt 5,93 mg Pt/l 1,5 mg Pt/l N-NH4 mg N/l mg N/l Page 62

63 Fecha del muestreo: Coagulante 117 p.p.m. 117 p.p.m. 7,6 7, SST 99 mg/l 22 mg/l DQO 349 mg O2/l 78,4 mg O2/l Pt 4,59 mg Pt/l 1,23 mg Pt/l N-NH4 29,45 mg N/l 17,05 mg N/l Page 63

64 Fecha del muestreo: Coagulante 117 p.p.m. 117 p.p.m. 7,5 7, ,7 SST 35 mg/l 47 mg/l DQO 104 mg O2/l 79,4 mg O2/l Pt 1,84 mg Pt/l 1,86 mg Pt/l N-NH4 23,8 mg N/l 11,56 mg N/l Page 64

65 Fecha del muestreo: Coagulante 117 p.p.m. 117 p.p.m. 7,7 7, SST 88 mg/l 139 mg/l DQO 228 mg O2/l 213 mg O2/l Pt 2,94 mg Pt/l 4 mg Pt/l N-NH4 24 mg N/l 5,21 mg N/l Page 65

66 Fecha del muestreo: Coagulante 117 p.p.m. 117 p.p.m. 8,1 8, SST 71 mg/l 23 mg/l DQO 250 mg O2/l 88,7 mg O2/l Pt 3,43 mg Pt/l 1,68 mg Pt/l N-NH4 25,1 mg N/l 13,6 mg N/l Page 66

67 Fecha del muestreo: Coagulante 117 p.p.m. 117 p.p.m. 7, , SST 66 mg/l 25 mg/l DQO 226 mg O2/l 74,9 mg O2/l Pt 2,35 mg Pt/l 1,7 mg Pt/l N-NH4 14,9 mg N/l 2,68 mg N/l Toxicidad u. T < 2 u. T Escherichia coli 6, ufc/ml Page 67

68 Fecha del muestreo: Coagulante 117 p.p.m. 117 p.p.m. 7, , SST 82 mg/l 23 mg/l DQO 340 mg O2/l 67,5 mg O2/l Pt 3,77 mg Pt/l 1,91 mg Pt/l N-NH4 16,3 mg N/l 3,07 mg N/l Page 68

69 Fecha del muestreo: Coagulante 117 p.p.m. 117 p.p.m. 7, , SST 81 mg/l 19 mg/l DQO 265 mg O2/l 85,4 mg O2/l Pt 4,46 mg Pt/l 2,13 mg Pt/l N-NH4 25,6 mg N/l 2,66 mg N/l Page 69

70 Fecha del muestreo: Coagulante 114 p.p.m. 120 p.p.m. 7, , SST 107 mg/l 18 mg/l DQO 392 mg O2/l 207 mg O2/l Pt 6,39 mg Pt/l 1,36 mg Pt/l N-NH4 33,3 mg N/l 3,8 mg N/l Page 70

71 Fecha del muestreo: Coagulante 114 p.p.m. 120 p.p.m. 7, , SST 103 mg/l 13 mg/l DQO 365 mg O2/l 54,4 mg O2/l Pt 4,37 mg Pt/l 0,668 mg Pt/l N-NH4 33,7 mg N/l 8,87 mg N/l Page 71

72 Fecha del muestreo: Coagulante 114 p.p.m. 120 p.p.m. 7,46 7, SST 143 mg/l 24 mg/l DQO 436 mg O2/l 57,3 mg O2/l Pt 6,27 mg Pt/l 0,719 mg Pt/l N-NH4 27,4 mg N/l 8,07 mg N/l Page 72

73 Fecha del muestreo: Coagulante 114 p.p.m. 120 p.p.m. 7, , SST 158 mg/l 51 mg/l DQO 504 mg O2/l 110 mg O2/l Pt 8,77 mg Pt/l 2,49 mg Pt/l N-NH4 24,9 mg N/l 12,2 mg N/l Page 73

74 Fecha del muestreo: Coagulante 114 p.p.m. 120 p.p.m. 7, ,37 943,6 SST 549 mg/l 9 mg/l DQO 904 mg O2/l 24,2 mg O2/l Pt 13 mg Pt/l 1,25 mg Pt/l N-NH4 35,8 mg N/l 3,27 mg N/l Page 74

75 Fecha del muestreo: Coagulante 114 p.p.m. 120 p.p.m , SST 148 mg/l 29 mg/l DQO 393 mg O2/l 72,2 mg O2/l Pt 8,04 mg Pt/l 1,68 mg Pt/l N-NH4 23,2 mg N/l 3,37 mg N/l Page 75

76 Fecha del muestreo: Coagulante 114 p.p.m. 120 p.p.m. 7, , SST 65 mg/l 59 mg/l DQO 471 mg O2/l 158 mg O2/l Pt 6,42 mg Pt/l 5,21 mg Pt/l N-NH4 25,6 mg N/l 22,3 mg N/l Page 76

77 Fecha del muestreo: Coagulante 114 p.p.m. 120 p.p.m. 7, , SST 106 mg/l 123 mg/l DQO 454 mg O2/l 233 mg O2/l Pt 6,98 mg Pt/l 5,83 mg Pt/l N-NH4 24,7 mg N/l 20,8 mg N/l Page 77

78 Fecha del muestreo: Coagulante 114 p.p.m. 120 p.p.m SST 110 mg/l 25 mg/l DQO 352 mg O2/l 56,9 mg O2/l Pt 4,92 mg Pt/l 0,599 mg Pt/l N-NH4 33,6 mg N/l 29,6 mg N/l Page 78

79 Fecha del muestreo: Coagulante 114 p.p.m. 120 p.p.m. 7, , SST 106 mg/l 43 mg/l DQO 469 mg O2/l 130 mg O2/l Pt 6,17 mg Pt/l 1,5 mg Pt/l N-NH4 29,2 mg N/l 27,4 mg N/l Page 79

80 Fecha del muestreo: Coagulante 114 p.p.m. 120 p.p.m. 7, , SST 141 mg/l 13 mg/l DQO 358 mg O2/l 37,2 mg O2/l Pt 5,73 mg Pt/l 0,76 mg Pt/l N-NH4 33,6 mg N/l 17,3 mg N/l Page 80

81 Fecha del muestreo: Coagulante 114 p.p.m. 120 p.p.m. 8, , SST 129 mg/l 17 mg/l DQO 429 mg O2/l 61,1 mg O2/l Pt 5,9 mg Pt/l 1,39 mg Pt/l N-NH4 36,3 mg N/l 7,42 mg N/l Page 81

82 Fecha del muestreo: Coagulante 114 p.p.m. 120 p.p.m. 7, , SST 144 mg/l 27 mg/l DQO 514 mg O2/l 94,3 mg O2/l Pt 7,02 mg Pt/l 1,71 mg Pt/l N-NH4 32,4 mg N/l 20,5 mg N/l Page 82

83 Fecha del muestreo: Coagulante 114 p.p.m. 120 p.p.m. 7, , SST 75 mg/l 10 mg/l DQO 336 mg O2/l 30,8 mg O2/l Pt 2,32 mg Pt/l < 0,5 mg Pt/l N-NH4 40,7 mg N/l 40,4 mg N/l Page 83

84 Fecha del muestreo: Coagulante 114 p.p.m. 120 p.p.m. 7, , SST 156 mg/l 149 mg/l DQO 399 mg O2/l 242 mg O2/l Pt 5,83 mg Pt/l 4,28 mg Pt/l N-NH4 32,8 mg N/l 30,2 mg N/l Page 84

85 Fecha del muestreo: Coagulante 112 p.p.m. 118 p.p.m. 7,9 7, SST 116 mg/l 32 mg/l DQO 335 mg O2/l 53,3 mg O2/l Pt 6,2 mg Pt/l 1,5 mg Pt/l N-NH4 45,3 mg N/l 33 mg N/l Page 85

86 Fecha del muestreo: Coagulante 112 p.p.m. 118 p.p.m. 7,9 7, SST 103 mg/l 30 mg/l DQO 315 mg O2/l 62,9 mg O2/l Pt 3 mg Pt/l 1,4 mg Pt/l N-NH4 28,5 mg N/l 23,7 mg N/l Page 86

87 Fecha del muestreo: Coagulante 112 p.p.m. 118 p.p.m. 7,9 7, SST 69 mg/l 32 mg/l DQO 258 mg O2/l 129 mg O2/l Pt 3,7 mg Pt/l 1,6 mg Pt/l N-NH4 29,7 mg N/l 21,9 mg N/l Page 87

88 Fecha del muestreo: Coagulante 112 p.p.m. 118 p.p.m. 7,5 7, SST 86 mg/l 6 mg/l DQO 341 mg O2/l 56,6 mg O2/l Pt 3,9 mg Pt/l < 0,5 mg Pt/l N-NH4 28,4 mg N/l 27,7 mg N/l Page 88

89 Fecha del muestreo: Coagulante 112 p.p.m. 118 p.p.m. 7,6 7, SST 129 mg/l 29 mg/l DQO 437 mg O2/l 171 mg O2/l Pt 5,6 mg Pt/l 2,4 mg Pt/l N-NH4 30,5 mg N/l 25,5 mg N/l Page 89

90 Fecha del muestreo: Coagulante 112 p.p.m. 118 p.p.m. 7,8 7, SST 122 mg/l 48 mg/l DQO 375 mg O2/l 119 mg O2/l Pt 4 mg Pt/l 1,4 mg Pt/l N-NH4 28,1 mg N/l 25,2 mg N/l Page 90

91 Fecha del muestreo: Coagulante 112 p.p.m. 118 p.p.m. 7,6 7, SST 81 mg/l 26 mg/l DQO 360 mg O2/l 103 mg O2/l Pt 4,5 mg Pt/l 0,892 mg Pt/l N-NH4 27,3 mg N/l 30,5 mg N/l Page 91

92 Fecha del muestreo: Coagulante 118 p.p.m. 101 p.p.m. 7,7 7, SST 81 mg/l 214 mg/l DQO 305 mg O2/l 324 mg O2/l Pt 3,02 mg Pt/l 5 mg Pt/l N-NH4 37,6 mg N/l 36 mg N/l Page 92

93 Fecha del muestreo: Coagulante 118 p.p.m. 101 p.p.m. 7,6 7, SST 360 mg/l 82 mg/l DQO 539 mg O2/l 348 mg O2/l Pt 8,48 mg Pt/l 4,97 mg Pt/l N-NH4 33 mg N/l 31,2 mg N/l Page 93

94 Fecha del muestreo: Coagulante 118 p.p.m. 101 p.p.m. 7,7 7, SST 220 mg/l 150 mg/l DQO 520 mg O2/l 172 mg O2/l Pt 7,2 mg Pt/l 3,35 mg Pt/l N-NH4 27,4 mg N/l 26,1 mg N/l Page 94

95 Fecha del muestreo: Coagulante 118 p.p.m. 101 p.p.m. 7,7 7, SST 90 mg/l 12 mg/l DQO 390 mg O2/l 48,8 mg O2/l Pt 6,31 mg Pt/l 0,675 mg Pt/l N-NH4 28 mg N/l 22,2 mg N/l Page 95

96 Fecha del muestreo: Coagulante 118 p.p.m. 101 p.p.m. 7,7 7, SST 73 mg/l 29 mg/l DQO 482 mg O2/l 120 mg O2/l Pt 6,1 mg Pt/l 4,63 mg Pt/l N-NH4 30,5 mg N/l 24,5 mg N/l Page 96

97 Fecha del muestreo: Coagulante 118 p.p.m. 101 p.p.m. 7,7 7, SST 95 mg/l 110 mg/l DQO 480 mg O2/l 230 mg O2/l Pt 7,23 mg Pt/l 2,61 mg Pt/l N-NH4 28,2 mg N/l 20,4 mg N/l Page 97

98 Fecha del muestreo: Coagulante 118 p.p.m. 101 p.p.m. 7,5 7, SST 120 mg/l 25 mg/l DQO 448 mg O2/l 83,7 mg O2/l Pt 6,33 mg Pt/l 0,87 mg Pt/l N-NH4 32,9 mg N/l 30 mg N/l Page 98

99 Fecha del muestreo: Coagulante 118 p.p.m. 101 p.p.m. 7,7 7, SST 121 mg/l 119 mg/l DQO 563 mg O2/l 287 mg O2/l Pt 6,3 mg Pt/l 8,05 mg Pt/l N-NH4 33,1 mg N/l 29,7 mg N/l Page 99

100 Fecha del muestreo: Coagulante 118 p.p.m. 101 p.p.m. 7,4 7, SST 101 mg/l 50 mg/l DQO 410 mg O2/l 60 mg O2/l Pt 5,4 mg Pt/l 0,7 mg Pt/l N-NH4 32,2 mg N/l 21,1 mg N/l Page 100

101 Fecha del muestreo: Coagulante 118 p.p.m. 101 p.p.m. 7,5 7, SST 140 mg/l 56 mg/l DQO 524 mg O2/l 174 mg O2/l Pt 5,64 mg Pt/l 3,26 mg Pt/l N-NH4 30,1 mg N/l 35,9 mg N/l Page 101

102 Fecha del muestreo: Coagulante 118 p.p.m. 101 p.p.m. 8,1 8, SST 124 mg/l 36 mg/l DQO 493 mg O2/l 146 mg O2/l Pt 5,63 mg Pt/l 2,53 mg Pt/l N-NH4 29,6 mg N/l 33,1 mg N/l Page 102

103 Fecha del muestreo: Coagulante 109 p.p.m. 104 p.p.m. 7, , SST 106 mg/l 120 mg/l DQO 421 mg O2/l 215 mg O2/l Pt 3,97 mg Pt/l 2,19 mg Pt/l N-NH4 30,2 mg N/l 33 mg N/l Page 103

104 Fecha del muestreo: Coagulante 109 p.p.m. 104 p.p.m , SST 127 mg/l 259 mg/l DQO 558 mg O2/l 455 mg O2/l Pt 6,74 mg Pt/l 5,49 mg Pt/l N-NH4 33,3 mg N/l 33,6 mg N/l Page 104

105 Fecha del muestreo: Coagulante 109 p.p.m. 104 p.p.m. 7, , SST 86 mg/l 16 mg/l DQO 294 mg O2/l 107 mg O2/l Pt 3,64 mg Pt/l < 0,5 mg Pt/l N-NH4 12,8 mg N/l 29,4 mg N/l Escherichia coli ufc/ml Toxicidad u. T < 2 u. T Page 105

106 Fecha del muestreo: Coagulante 109 p.p.m. 104 p.p.m. 7, , SST 86 mg/l 28 mg/l DQO 396 mg O2/l 145 mg O2/l Pt 4,85 mg Pt/l 1,1 mg Pt/l N-NH4 37,2 mg N/l 27,3 mg N/l Page 106

107 Fecha del muestreo: Coagulante 109 p.p.m. 104 p.p.m. 7, , SST 508 mg/l 55 mg/l DQO 779 mg O2/l 183 mg O2/l Pt 7,56 mg Pt/l 1,74 mg Pt/l N-NH4 26,2 mg N/l 33,9 mg N/l Page 107

108 Fecha del muestreo: Coagulante 109 p.p.m. 104 p.p.m. 7, , SST 83 mg/l 44 mg/l DQO 492 mg O2/l 203 mg O2/l Pt 5,04 mg Pt/l 5,33 mg Pt/l N-NH4 28,6 mg N/l 33,9 mg N/l Page 108

109 Fecha del muestreo: Coagulante 109 p.p.m. 104 p.p.m ,7 896 SST 177 mg/l 15 mg/l DQO 415 mg O2/l 55 mg O2/l Pt 4,25 mg Pt/l < 0,5 mg Pt/l N-NH4 10,9 mg N/l 11 mg N/l Page 109

110 Fecha del muestreo: Coagulante 109 p.p.m. 104 p.p.m. 7, , SST 133 mg/l 7 mg/l DQO 246 mg O2/l 39 mg O2/l Pt 4,25 mg Pt/l 0,641 mg Pt/l N-NH4 41,3 mg N/l 31,8 mg N/l Page 110

111 Fecha del muestreo: Coagulante 109 p.p.m. 104 p.p.m. 7, , SST 145 mg/l 24 mg/l DQO 466 mg O2/l 105 mg O2/l Pt 6,03 mg Pt/l < 0,5 mg Pt/l N-NH4 27,7 mg N/l 31,1 mg N/l Page 111

112 Fecha del muestreo: Coagulante 53 p.p.m. 96 p.p.m. 7, , SST 242 mg/l 13 mg/l DQO 722 mg O2/l 72,5 mg O2/l Pt 7,34 mg Pt/l 2,01 mg Pt/l N-NH4 42 mg N/l 35 mg N/l Page 112

113 Fecha del muestreo: Coagulante 53 p.p.m. 96 p.p.m. 7, ,5 903 SST 94 mg/l 80 mg/l DQO 376 mg O2/l 137 mg O2/l Pt 3,72 mg Pt/l 1,69 mg Pt/l N-NH4 20,6 mg N/l 8,97 mg N/l Escherichia coli 1, ufc/ml Toxicidad u. T < 2 u. T Page 113

114 Fecha del muestreo: Coagulante 53 p.p.m. 96 p.p.m. 7, , SST 151 mg/l 59 mg/l DQO 574 mg O2/l 156 mg O2/l Pt 6,21 mg Pt/l 5 mg Pt/l N-NH4 29,2 mg N/l 39,8 mg N/l HAY VERTIDOS INCONTROLADOS EN LA DEPURADORA Page 114

115 Fecha del muestreo: Coagulante 53 p.p.m. 96 p.p.m. 7, SST 117 mg/l 112 mg/l DQO 530 mg O2/l 323 mg O2/l Pt 5,8 mg Pt/l 6,85 mg Pt/l N-NH4 35 mg N/l 43,2 mg N/l HAY VERTIDOS INCONTROLADOS EN LA DEPURADORA Page 115

116 Fecha del muestreo: Coagulante 53 p.p.m. 96 p.p.m. 7, , SST 113 mg/l 67 mg/l DQO 301 mg O2/l 160 mg O2/l Pt 5,39 mg Pt/l 1,56 mg Pt/l N-NH4 41,3 mg N/l 32,8 mg N/l Page 116

117 Fecha del muestreo: Coagulante 53 p.p.m. 96 p.p.m. 7, , SST 158 mg/l 67 mg/l DQO 442 mg O2/l 186 mg O2/l Pt 6,11 mg Pt/l 2,23 mg Pt/l N-NH4 42,5 mg N/l 34,9 mg N/l Page 117

118 Fecha del muestreo: Coagulante 53 p.p.m. 96 p.p.m , SST 121 mg/l 116 mg/l DQO 515 mg O2/l 363 mg O2/l Pt 6,03 mg Pt/l 7,23 mg Pt/l N-NH4 2,76 mg N/l 1,58 mg N/l Page 118

119 Fecha del muestreo: Coagulante 52 p.p.m. 97 p.p.m. 7,7 7, SST 154 mg/l 370 mg/l DQO 470 mg O2/l 596 mg O2/l Pt 11 mg Pt/l 7,48 mg Pt/l N-NH4 34,7 mg N/l 3,4 mg N/l Ecoli 3,6 x 10 3 ufc/ml Toxicidad u. T < 2 u. T Page 119

120 Fecha del muestreo: Coagulante 52 p.p.m. 97 p.p.m. 7,7 7, SST 185 mg/l 58 mg/l DQO 612 mg O2/l 227 mg O2/l Pt 7,98 mg Pt/l 4,45 mg Pt/l N-NH4 40,7 mg N/l 33,3 mg N/l Page 120

121 Fecha del muestreo: Coagulante 52 p.p.m. 97 p.p.m. 7,7 7, SST 105 mg/l 349 mg/l DQO 275 mg O2/l 569 mg O2/l Pt 3,61 mg Pt/l 5,87 mg Pt/l N-NH4 17,5 mg N/l 26,9 mg N/l Page 121

122 Fecha del muestreo: Coagulante 52 p.p.m. 97 p.p.m. 7,9 7, SST 105 mg/l 40 mg/l DQO 252 mg O2/l 148 mg O2/l Pt 3,78 mg Pt/l 2,06 mg Pt/l N-NH4 26,6 mg N/l 55 mg N/l Page 122

123 Fecha del muestreo: Coagulante 52 p.p.m. 97 p.p.m. 7,7 7, SST 7 mg/l 33 mg/l DQO 341 mg O2/l 126 mg O2/l Pt 3,86 mg Pt/l 1,24 mg Pt/l N-NH4 36,1 mg N/l 36,7 mg N/l Page 123

124 Fecha del muestreo: Coagulante 52 p.p.m. 97 p.p.m. 7,7 7, SST mg/l mg/l DQO 274 mg O2/l 152 mg O2/l Pt 3,96 mg Pt/l 1,62 mg Pt/l N-NH4 26,4 mg N/l 25,5 mg N/l Page 124

125 Fecha del muestreo: Coagulante 52 p.p.m. 97 p.p.m. 7,7 7, SST 37 mg/l 22 mg/l DQO 142 mg O2/l 76 mg O2/l Pt 2,98 mg Pt/l 0,687 mg Pt/l N-NH4 23,4 mg N/l 31,4 mg N/l Page 125

126 Fecha del muestreo: Coagulante 52 p.p.m. 97 p.p.m. 7,8 7, SST 208 mg/l 47 mg/l DQO 603 mg O2/l 192 mg O2/l Pt 6,36 mg Pt/l 3,43 mg Pt/l N-NH4 24,6 mg N/l 26,5 mg N/l Page 126

127 Fecha del muestreo: Coagulante 52 p.p.m. 97 p.p.m. 7,8 7, SST 111 mg/l 36 mg/l DQO 423 mg O2/l 139 mg O2/l Pt 4,75 mg Pt/l 1,83 mg Pt/l N-NH4 32,1 mg N/l 39 mg N/l Page 127

128 Fecha del muestreo: Coagulante 52 p.p.m. 98 p.p.m. 8,2 8, SST 150 mg/l 39 mg/l DQO 430 mg O2/l 177 mg O2/l Pt 5,35 mg Pt/l 1,07 mg Pt/l N-NH4 12,6 mg N/l 11,5 mg N/l Page 128

129 Fecha del muestreo: Coagulante 52 p.p.m. 98 p.p.m. 7,7 7, SST 120 mg/l 28 mg/l DQO 467 mg O2/l 123 mg O2/l Pt 5,26 mg Pt/l 1,14 mg Pt/l N-NH4 28,5 mg N/l 37,9 mg N/l Page 129

130 Fecha del muestreo: Coagulante 52 p.p.m. 98 p.p.m. 7,7 7, SST 104 mg/l 43 mg/l DQO 443 mg O2/l 157 mg O2/l Pt 5,49 mg Pt/l 2,91 mg Pt/l N-NH4 34 mg N/l 30,3 mg N/l Page 130

131 4.2. Microorganisms Control In order to know the state of the biological reactor microorganism in the prototype, it was necessary to check and control the status of them weekly. Some samples was observed each month in order to anticipate potentials problems with the prototype. From figures A1 to A42, it can be seen that the microorganism are in good conditions during all the time of demonstration actions. Page 131

132 Figure A1: Optical microscopy photography of biological reactor microorganism in the prototype 29/04/15 Figure A2: Optical microscopy photography of biological reactor microorganism in the prototype 05/05/15 Figure A3: Optical microscopy photography of biological reactor microorganism in the prototype 19/05/15 Figure A4: Optical microscopy photography of biological reactor microorganism in the prototype 26/05/15 Figure A5: Optical microscopy photography of biological reactor microorganism in the prototype 11/06/15 Figure A6: Optical microscopy photography of biological reactor microorganism in the prototype 18/06/15 Page 132

133 Figure A7: Optical microscopy photography of biological reactor microorganism in the prototype 25/06/15 Figure A8: Optical microscopy photography of biological reactor microorganism in the prototype 02/07/15 Figure A9: Optical microscopy photography of biological reactor microorganism in the prototype 09/07/15 Figure A10: Optical microscopy photography of biological reactor microorganism in the prototype 16/07/15 Figure A11: Optical microscopy photography of biological reactor microorganism in the prototype 23/0715 Figure A12: Otical microscopy photography of biological reactor microorganism in the prototype 05/08/15 Page 133

134 of Figure A13: Optical microscopy photography biological reactor microorganism in the prototype 12/08/15 Figure A14: Optical microscopy photography of biological reactor microorganism in the prototype 10/09/15 Figure A15: Optical microscopy photography of biological reactor microorganism in the prototype 17/09/15 Figure A16: Optical microscopy photography of biological reactor microorganism in the prototype 06/10/15 Figure A17: Optical microscopy photography of biological reactor microorganism in the prototype 13/10/15 Figure A18: Optical microscopy photography of biological reactor microorganism in the prototype 20/10/15 Page 134

135 Figure A19: Optical microscopy photography of biological reactor microorganism in the prototype 27/10/15 Figure A20: Optical microscopy photography of biological reactor microorganism in the prototype 10/11/15 Figure A21: Optical microscopy photography of biological reactor microorganism in the prototype 17/11/15 Figure A22: Optical microscopy photography of biological reactor microorganism in the prototype 24/11/15 Figure A23: Optical microscopy photography of biological reactor microorganism in the prototype 03/12/15 Figure A24: Optical microscopy photography of biological reactor microorganism in the prototype 17/12/15 Page 135

136 Figure A25: Optical microscopy photography of biological reactor microorganism in the prototype 07/01/16 Figure A26: Optical microscopy photography of biological reactor microorganism in the prototype 14/01/16 Figure A27: Optical microscopy photography of biological reactor microorganism in the prototype 21/01/16 Figure A28: Optical microscopy photography of biological reactor microorganism in the prototype 02/02/16 Figure A29: Optical microscopy photography of biological reactor microorganism in the prototype 16/02/16 Figure A30: Optical microscopy photography of biological reactor microorganism in the prototype 23/02/16 Page 136

137 Figure A31: Optical microscopy photography of biological reactor microorganism in the prototype 01/03/16 Figure A32: Optical microscopy photography of biological reactor microorganism in the prototype 08/03/16 Figure A33: Optical microscopy photography of biological reactor microorganism in the prototype 15/03/16 Figure A34: Optical microscopy photography of biological reactor microorganism in the prototype 22/03/16 Figure A35: Optical microscopy photography of biological reactor microorganism in the prototype 07/04/16 Figure A36: Optical microscopy photography of biological reactor microorganism in the prototype 14/04/16 Page 137

138 Figure A37: Optical microscopy photography of biological reactor microorganism in the prototype 26/04/16 Figure A38: Optical microscopy photography of biological reactor microorganism in the prototype 03/05/16 Figure A39: Optical microscopy photography of biological reactor microorganism in the prototype 12/05/16 Figure A40: Optical microscopy photography of biological reactor microorganism in the prototype 19/05/16 Figure A41: Optical microscopy photography of biological reactor microorganism in the prototype 26/05/16 Figure A42: Optical microscopy photography of biological reactor microorganism in the prototype 02/06/16 Page 138